Teachntest
SEPTEMBER 12, 2022
O2 Tablets Two antibiotics are put together to make O2 tablets. It is used to treat infections caused by both bacteria and parasites. It works well to treat a wide variety of bacterial infections, including those in the teeth, lungs, digestive tract, urinary tract, and genital tract. It’s best to take an O2 Tablet with. Read more
Eversana Intouch
MARCH 13, 2024
Our team is on the ground at SXSW 2024, and as we navigate through the bustling streets of downtown Austin, Texas — where the magic of immersive brand experiences dress the streets — we can’t help but feel the pulse of innovation surrounding us. The “ugly” aspects, the side effects, and the unpleasant truths are all concealed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Medico Reach
FEBRUARY 8, 2023
With the use of trailblazing digital platforms, cost-effective technologies, big data analytics, blockchain, and artificial intelligence (AI), the landscape is undergoing a massive transition. The Grand View Research published a report highlighting the stark growth prospects of the pharma industry. billion during 2020-2024.
pharmaphorum
JUNE 23, 2022
The Swiss pharma group is paying $75 million upfronting cash and equity to get the ball rolling on the collaboration, with another $1.4 It is a challenging proposition, however, as delivery of the therapeutic gene sequences to cells can be difficult and raises the risk of insertion mutations that can lead to side effects, including cancer.
pharmaphorum
AUGUST 19, 2022
Grünenthal has moved its painkiller resiniferatoxin into phase 3 trials in patients with osteoarthritis, hoping to find an option that sidesteps the side effects and addictive potential of opioid drugs.
pharmaphorum
OCTOBER 10, 2022
month mPFS with Keytruda plus chemo, with fewer side effects. A key readout for BMS will be a front-line phase 2 study of its combination in NSCLC due to read out in 2024, but its unclear if that could support approval so Immutep could be able to maintain a lead in this type of cancer.
pharmaphorum
JULY 26, 2022
NewAmsterdam Pharma has charted out a route to a Nasdaq listing by merging with black cheque company Frazier Lifesciences in a deal that will provide additional cash for its main drug candidate – oral CETP inhibitor obicetrapib. Remember CETP? So why will obicetrapib avoid the pitfalls of its predecessors?
Expert insights. Personalized for you.
52 
Let's personalize your content